Antibiotic Use Prior to Hospital Presentation Among Individuals With Suspected Enteric Fever in Nepal, Bangladesh, and Pakistan.


Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
01 12 2020
Historique:
entrez: 1 12 2020
pubmed: 2 12 2020
medline: 28 4 2021
Statut: ppublish

Résumé

Antibiotic use prior to seeking care at a hospital may reduce the sensitivity of blood culture for enteric fever, with implications for both clinical care and surveillance. The Surveillance for Enteric Fever in Asia Project (SEAP) is a prospective study of enteric fever incidence in Nepal, Bangladesh, and Pakistan. Nested within SEAP, we evaluated the accuracy of self-reported antibiotic use and investigated the association between antibiotic use and blood culture positivity. Between November 2016 and April 2019, we collected urine samples among a subset of SEAP participants to test for antibiotic use prior to the hospital visit using an antibacterial activity assay. All participants were asked about recent antibiotic use and had a blood culture performed. We used mixed-effect logit models to evaluate the effect of antimicrobial use on blood culture positivity, adjusted for markers of disease severity. We enrolled 2939 patients with suspected enteric fever. Antibiotics were detected in 39% (1145/2939) of urine samples. The correlation between measured and reported antibiotic use was modest (κ = 0.72). After adjusting for disease severity, patients with antibiotics in their urine were slightly more likely to be blood culture positive for enteric fever; however, the effect was not statistically significant (prevalence ratio, 1.22 [95% confidence interval, .99-1.50]). The reliability of self-reported prior antibiotic use was modest among individuals presenting with fever to tertiary hospitals. While antibiotics are likely to reduce the sensitivity of blood culture, our findings indicate that there is still considerable value in performing blood culture for individuals reporting antibiotic use.

Sections du résumé

BACKGROUND
Antibiotic use prior to seeking care at a hospital may reduce the sensitivity of blood culture for enteric fever, with implications for both clinical care and surveillance. The Surveillance for Enteric Fever in Asia Project (SEAP) is a prospective study of enteric fever incidence in Nepal, Bangladesh, and Pakistan. Nested within SEAP, we evaluated the accuracy of self-reported antibiotic use and investigated the association between antibiotic use and blood culture positivity.
METHODS
Between November 2016 and April 2019, we collected urine samples among a subset of SEAP participants to test for antibiotic use prior to the hospital visit using an antibacterial activity assay. All participants were asked about recent antibiotic use and had a blood culture performed. We used mixed-effect logit models to evaluate the effect of antimicrobial use on blood culture positivity, adjusted for markers of disease severity.
RESULTS
We enrolled 2939 patients with suspected enteric fever. Antibiotics were detected in 39% (1145/2939) of urine samples. The correlation between measured and reported antibiotic use was modest (κ = 0.72). After adjusting for disease severity, patients with antibiotics in their urine were slightly more likely to be blood culture positive for enteric fever; however, the effect was not statistically significant (prevalence ratio, 1.22 [95% confidence interval, .99-1.50]).
CONCLUSIONS
The reliability of self-reported prior antibiotic use was modest among individuals presenting with fever to tertiary hospitals. While antibiotics are likely to reduce the sensitivity of blood culture, our findings indicate that there is still considerable value in performing blood culture for individuals reporting antibiotic use.

Identifiants

pubmed: 33258935
pii: 6013563
doi: 10.1093/cid/ciaa1333
pmc: PMC7705873
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

S285-S292

Subventions

Organisme : NIAID NIH HHS
ID : L30 AI147158
Pays : United States

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America.

Références

mBio. 2018 Feb 20;9(1):
pubmed: 29463654
Bull World Health Organ. 2004 May;82(5):346-53
pubmed: 15298225
Infect Drug Resist. 2018 Jan 18;11:133-145
pubmed: 29403295
PLoS Negl Trop Dis. 2019 May 8;13(5):e0007303
pubmed: 31067228
Infect Dis Clin North Am. 2004 Mar;18(1):111-25
pubmed: 15081508
Clin Infect Dis. 2019 Mar 5;68(6):949-955
pubmed: 30020426
Am J Trop Med Hyg. 1999 Mar;60(3):397-9
pubmed: 10466966
New Microbiol. 2009 Jan;32(1):25-30
pubmed: 19382666
J Infect Dis. 2018 Nov 10;218(suppl_4):S268-S276
pubmed: 30184162
Lancet Infect Dis. 2019 Apr;19(4):369-381
pubmed: 30792131
Front Microbiol. 2017 Sep 19;8:1794
pubmed: 28970824
PLoS Negl Trop Dis. 2019 Nov 15;13(11):e0007868
pubmed: 31730615
Pediatrics. 1968 Jan;41(1):151-3
pubmed: 5635481
Cureus. 2018 Apr 5;10(4):e2428
pubmed: 29876150
J Infect Dis. 2018 Nov 10;218(suppl_4):S255-S267
pubmed: 30307563
BMC Public Health. 2014 Aug 14;14:847
pubmed: 25124712
J Infect Dis. 2018 Nov 10;218(suppl_4):S188-S194
pubmed: 30304505
J Clin Epidemiol. 1999 Jun;52(6):539-45
pubmed: 10408993
N Engl J Med. 2002 Nov 28;347(22):1770-82
pubmed: 12456854
Vaccine. 2015 Jun 19;33 Suppl 3:C8-15
pubmed: 25937611
Nat Med. 2006 Jun;12(6):636-41
pubmed: 16751768
Can Med Assoc J. 1978 Nov 18;119(10):1183-7
pubmed: 743658
JNMA J Nepal Med Assoc. 2018 Jul-Aug;56(212):740-744
pubmed: 30387460
Rev Infect Dis. 1985 Mar-Apr;7(2):244-56
pubmed: 3890097
J Clin Invest. 1968 Oct;47(10):2374-90
pubmed: 4877682
J Infect Dis. 2019 Oct 8;220(10):1655-1666
pubmed: 31192364
Clin Microbiol Rev. 2015 Oct;28(4):901-37
pubmed: 26180063
Kidney Int. 2013 Apr;83(4):548-50
pubmed: 23538695

Auteurs

Krista Vaidya (K)

Dhulikhel Hospital, Kathmandu University Hospital, Dhulikhel, Nepal.

Kristen Aiemjoy (K)

Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California, USA.

Farah N Qamar (FN)

Department of Pediatrics and Child Health, Aga Khan University Karachi, Pakistan.

Samir K Saha (SK)

Child Health Research Foundation, Department of Microbiology, Dhaka Shishu Hospital, Dhaka, Bangladesh.
Bangladesh Institute of Child Health, Dhaka Shishu Hospital, Sher-E-Bangla Nagar, Dhaka, Bangladesh.

Dipesh Tamrakar (D)

Dhulikhel Hospital, Kathmandu University Hospital, Dhulikhel, Nepal.

Shiva R Naga (SR)

Dhulikhel Hospital, Kathmandu University Hospital, Dhulikhel, Nepal.

Shampa Saha (S)

Child Health Research Foundation, Department of Microbiology, Dhaka Shishu Hospital, Dhaka, Bangladesh.

Caitlin Hemlock (C)

Applied Epidemiology, Sabin Vaccine Institute, Washington, DC, USA.

Ashley T Longley (AT)

National Foundation for the Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Kashmira Date (K)

National Foundation for the Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Isaac I Bogoch (II)

Department of Medicine, University of Toronto, Toronto, Ontario, Canada.

Denise O Garrett (DO)

Applied Epidemiology, Sabin Vaccine Institute, Washington, DC, USA.

Stephen P Luby (SP)

Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California, USA.

Jason R Andrews (JR)

Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH